Angiocrine Fund, LP is a private equity fund based in Nashville, Tennessee. According to its most recent Form D, filed Jan 17, 2013, it has sold $1,350,000 of interests to 6 investors since its first sale in Jan 2013. The minimum investment it accepts from an outside investor is $1,000. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. Related persons named in the filing include AngioC Management, LLC; W Daniel; Jeffrey Port.
- Total raised
- $1,350,000Cumulative sales reported on Form D
- Investors
- 6
- First sale
- Jan 2, 2013
- Minimum investment
- $1,000
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Other exemption
- Key people and entities
- AngioC Management, LLC; W Daniel; Jeffrey Port
- Latest Form D
- Jan 17, 2013
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about Angiocrine Fund, LP
What is the minimum investment for Angiocrine Fund, LP?
According to its latest Form D, filed Jan 17, 2013, the minimum investment Angiocrine Fund, LP accepts from an outside investor is $1,000.
Who can invest in Angiocrine Fund, LP?
Angiocrine Fund, LP is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1).
How much has Angiocrine Fund, LP raised?
Angiocrine Fund, LP reports $1,350,000 sold from 6 investors on its Form D filed Jan 17, 2013. This is cumulative sales since the offering began, not current assets or performance.
Where is Angiocrine Fund, LP based?
Angiocrine Fund, LP is based in Nashville, Tennessee.
When did Angiocrine Fund, LP launch?
Angiocrine Fund, LP reports its first sale in Jan 2013.
Size compared with every private equity fund
Raised more than 46% of the 76 private equity funds based in Tennessee, and more than 23% of all 8,950 that report sales.